Three new copper(II) linear trinuclear compounds are reported, all of which were synthesized in-situ, with the general formula [Cu3(L)4](CF3SO3)2(Y)x, where L is the dehydronated ligand: N,N′-bis(pyridine-2-yl)formamidine (abbreviated as Hpdf), N,N′-bis(pyrimidine-2-yl)formamidine (abbreviated as Hpmf) and N,N′-bis(5-methylpyridine-2-yl)formamidine (abbreviated as Hmpdf), Y = EtOH or H2O and x = 0.5–1.5. The compounds were characterized by X-ray diffraction, IR, LF, and EPR spectroscopy and by magnetic susceptibility down to 4 K. The structure of the compound [Cu3(pmf)4](CF3SO3)2(H2O)1/2 was determined by X-ray crystallography; it was found to crystallise in the triclinic space group P–1 with a = 8.529(5), b = 15.760(5), c = 19.639(5) Å, α = 101.793(5), β = 101.263(5), γ = 102.389(5)°, Z = 2. The structure [Cu–Cu–Cu angle 174.96(11)°] consists of four nearly flat molecules of the ligand, which contribute to the propeller-type structure around the Cu–Cu–Cu axis. A strong antiferromagnetic interaction between the CuII ions is observed with calculated J values, based on the Hamiltonian H = –2J(S1·S2 + S2·S3) – 2J′·S1·S3, of –174(1) cm−1, –120(1) cm−1, and –167(1) cm−1 for the compounds studied with L = pdf, pmf, and mpdf, respectively. These values are in agreement with an S = 1/2 ground state below temperatures of 120–160 K.
No takes yet. Share an insight, caveat, or question.
Albada et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: